Call-On-Doc review

What it is

Call-On-Doc, Inc. is a Dallas-based telehealth company, operating since 2017, that treats more than 150 conditions online, from urgent care and STDs to mental health, dermatology and primary care, with most visits priced as flat fees. It says it has more than two million active patients and providers licensed wherever its patients live, so coverage is nationwide. Weight loss is one of its service lines: the program prescribes compounded semaglutide or tirzepatide delivered to your home, lower-dose microdosing versions, or brand-name medications sent to a pharmacy you choose. The site displays a LegitScript seal whose number checks out. Its terms include binding arbitration and a class-action waiver, and its mailing address is on Walnut Hill Lane in Dallas.

How it works

You complete a medical intake, which takes five to ten minutes, covering your history, current medications, allergies and any information the provider asks for. A licensed provider reviews it, usually the same day and often within one to two hours, and may contact you through the secure portal, by phone or by video if more information is needed. If treatment is appropriate, you get a personalized plan: home-delivery patients receive their compounded medication each month, while care-only patients have the prescription sent to their chosen pharmacy. Monthly programs include ongoing provider oversight, dose adjustments and 24/7 medical support. If you're already on semaglutide or tirzepatide elsewhere, the provider may continue your current dose rather than restart you. If you aren't approved, the order isn't processed, and the provider may suggest other options.

Pricing transparency

There are three ways to pay. The full-strength all-in-one plan, with care and home delivery, is $250 a month for compounded semaglutide and $375 for compounded tirzepatide. The microdosing plan is $185 and $285. On both, the monthly price stays the same as your dose changes and includes the medication, provider management and dose adjustments. The care-only plan is $75 for a prescription for Zepbound, Wegovy, Ozempic, Mounjaro, Saxenda, Contrave, oral semaglutide or Foundayo, with the drug billed by your pharmacy, through insurance if your plan covers it or at cash price; an Rx savings card is available. Insurance can't be used for the home-delivery or microdose plans. You can cancel a subscription any time before the next billing cycle from your patient profile. Its general refund policy refunds you fully if it can't treat you or if you cancel before a provider reviews your case, but not after a prescription is sent.

Branded vs compounded

The home-delivery plans use compounded semaglutide and compounded tirzepatide, which the FAQ describes as prepared by licensed compounding pharmacies with the same active ingredients as the brand-name drugs; the specific pharmacy isn't named. Compounded versions aren't FDA-approved and haven't been tested in the trials behind the brand-name products, a point the program page doesn't stress. The care-only route covers FDA-approved drugs, including Wegovy, Zepbound, Ozempic, Mounjaro and Saxenda, plus oral options, filled at retail or online pharmacies of your choice. That makes Call-On-Doc a simple way to get a brand-name prescription if your insurance covers it. A search of the FDA warning-letter database under the Call-On-Doc name returned no letters.

Pros and watch-outs

The evidence behind what Call-On-Doc prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How Call-On-Doc compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Eden

  Compounded or branded GLP-1 through one consumer telehealth account

  See Eden →
• WellMedRx

  Compounded tirzepatide with a named clinician network and pharmacy

  See WellMedRx →
• Lemonaid Health

  Cash-pay buyers who want a low membership fee, a month-to-month compounded plan and a long-established telehealth brand

  See Lemonaid Health →

More GLP-1 telehealth reviews: Vyvron · Lighter You · Pallas Health · AHBARx · Alinwell · Andrew Meds